Cell Microsystems

Cell Microsystems is a biotechnology startup founded in 2010 and based in the United States. The company's slogan, "Generate more monoclonal colonies from single cells, faster with less effort," encapsulates its mission to revolutionize single cell biology. With its proprietary CellRaft® Technology, Cell Microsystems offers innovative products for single cell biology, enabling high-efficiency clonal propagation from single cells under standard culture conditions. This technology allows for the sorting and isolation of single cells, resulting in unperturbed phenotypes and high viability. The company's recent milestone includes a $6.50M Series B investment led by Telegraph Hill Partners on 23 August 2023. This significant investment reflects the investor confidence in Cell Microsystems' potential and the growing importance of single cell biology in the biotechnology industry. The funding will likely contribute to the further development and commercialization of their technologies, as well as support the company's goal of making cell separation technology available for every lab. Cell Microsystems' approach, coupled with the AIR System automated imaging platform, allows users to track and trace individual cells in real-time through cell division, imaging, propagation, and collection for downstream analysis. Their scalable solutions address the need for efficient and effective cell isolation and have the potential to greatly impact research and development in the biotechnology sector. In conclusion, Cell Microsystems' innovative technology and recent investment position the company for further growth and impact in the biotechnology industry, exemplifying its potential to drive advancements in single cell biology.